Katrine Bosley

Katrine Bosley

Presidente presso
Arrakis Therapeutics, Inc.
58 anni
Health Technology
Finance
Commercial Services

Profilo

Katrine S.
Bosley
is currently the Chairman at Arrakis Therapeutics, Inc. and the Director at Biotechnology Innovation Organization.
She is also a Venture Partner at Advent Venture Partners LLP.
Previously, she served as the President & Chief Executive Officer at Avila Therapeutics, Inc. and Editas Medicine, Inc. She was also the Chairman at Genocea Biosciences, Inc. and an Independent Non-Executive Director at Galapagos NV.
Additionally, she held positions as the Director-Decision Support at Biogen, Inc., Principal at Alkermes, Inc., and Vice President-Strategic Operations at Adnexus.
She has also worked at Massachusetts Eye & Ear Infirmary, Inc. and Celgene LLC.
Ms. Bosley received her undergraduate degree from Cornell University.

Posizioni attive di Katrine Bosley

SocietàPosizioneInizio
Direttore/Membro del Consiglio 01/06/2015
Direttore/Membro del Consiglio -
Presidente 21/11/2019
Investitore di Private Equity 01/05/2022

Precedenti posizioni note di Katrine Bosley

SocietàPosizioneFine
LAKEFRONT BIOTHERAPEUTICS NV Direttore/Membro del Consiglio 26/04/2022
EDITAS MEDICINE, INC. Amministratore Delegato 01/03/2019
Celgene LLC
Corporate Officer/Principal 01/05/2012
Amministratore Delegato 01/03/2012
Corporate Officer/Principal 01/01/2008
Vedi nel dettaglio l'esperienza di Katrine Bosley

Formazione di Katrine Bosley

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

91

Relazioni di 1° grado

15

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private15

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

Celgene LLC

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Katrine Bosley
-40% : Prolongation exceptionnelle ➤➤➤➤
g
:
:
ENTRA ORA